Garda Capital Partners LP Has $1.02 Million Stock Holdings in SPDR S&P Biotech ETF $XBI

Garda Capital Partners LP lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 45.6% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 12,265 shares of the exchange traded fund’s stock after selling 10,287 shares during the quarter. Garda Capital Partners LP’s holdings in SPDR S&P Biotech ETF were worth $1,017,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Prime Capital Investment Advisors LLC grew its stake in SPDR S&P Biotech ETF by 37.9% in the second quarter. Prime Capital Investment Advisors LLC now owns 9,939 shares of the exchange traded fund’s stock valued at $824,000 after purchasing an additional 2,729 shares in the last quarter. Cerity Partners LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 5.8% in the 1st quarter. Cerity Partners LLC now owns 18,605 shares of the exchange traded fund’s stock valued at $1,509,000 after buying an additional 1,016 shares during the last quarter. Farther Finance Advisors LLC grew its stake in shares of SPDR S&P Biotech ETF by 574.5% in the second quarter. Farther Finance Advisors LLC now owns 7,082 shares of the exchange traded fund’s stock valued at $587,000 after buying an additional 6,032 shares in the last quarter. N.E.W. Advisory Services LLC acquired a new position in SPDR S&P Biotech ETF during the first quarter worth $95,000. Finally, Investment Partners Asset Management Inc. raised its position in SPDR S&P Biotech ETF by 4.0% during the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock worth $270,000 after acquiring an additional 125 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $108.96 on Monday. The company has a fifty day moving average price of $102.21 and a two-hundred day moving average price of $90.50. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $113.21. The stock has a market cap of $6.61 billion, a P/E ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.